Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
Saved in:
| Title: | Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions. |
|---|---|
| Authors: | Marshall AD; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia; Centre for Social Research in Health, University of New South Wales, Sydney, NSW, Australia. Electronic address: amarshall@kirby.unsw.edu.au., Willing AR; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Kairouz A; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Cunningham EB; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Wheeler A; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., O'Brien N; Macquarie University, Sydney, NSW, Australia., Perera V; Macquarie University, Sydney, NSW, Australia., Ward JW; Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA., Hiebert L; Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA., Degenhardt L; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia., Hajarizadeh B; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Colledge S; National Drug Research Institute, Curtin University, Perth, WA, Australia., Hickman M; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Jawad D; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Lazarus JV; Barcelona Institute for Global Health (IS Global), Hospital Clinic, University of Barcelona, Barcelona, Spain; CUNY Graduate School of Public Health and Health Policy, New York, NY, USA., Matthews GV; Therapeutic and Vaccine Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia; St Vincent's Hospital, Darlinghurst, Sydney, NSW, Australia., Scheibe A; TB HIV Care, Cape Town, South Africa; Community Orientated, Primary Care Research Unit, Department of Family Medicine, University of Pretoria, Pretoria, South Africa., Vickerman P; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Dore GJ; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Grebely J; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia. |
| Corporate Authors: | Global HCV and HIV Treatment Restrictions Group |
| Source: | The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2024 Apr; Vol. 9 (4), pp. 366-382. Date of Electronic Publication: 2024 Feb 15. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-1253 (Electronic) NLM ISO Abbreviation: Lancet Gastroenterol Hepatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38367631 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Marshall+AD%22">Marshall AD</searchLink>; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia; Centre for Social Research in Health, University of New South Wales, Sydney, NSW, Australia. Electronic address: amarshall@kirby.unsw.edu.au.<br /><searchLink fieldCode="AU" term="%22Willing+AR%22">Willing AR</searchLink>; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Kairouz+A%22">Kairouz A</searchLink>; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Cunningham+EB%22">Cunningham EB</searchLink>; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Wheeler+A%22">Wheeler A</searchLink>; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22O'Brien+N%22">O'Brien N</searchLink>; Macquarie University, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Perera+V%22">Perera V</searchLink>; Macquarie University, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Ward+JW%22">Ward JW</searchLink>; Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA.<br /><searchLink fieldCode="AU" term="%22Hiebert+L%22">Hiebert L</searchLink>; Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA.<br /><searchLink fieldCode="AU" term="%22Degenhardt+L%22">Degenhardt L</searchLink>; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Hajarizadeh+B%22">Hajarizadeh B</searchLink>; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Colledge+S%22">Colledge S</searchLink>; National Drug Research Institute, Curtin University, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Hickman+M%22">Hickman M</searchLink>; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Jawad+D%22">Jawad D</searchLink>; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Lazarus+JV%22">Lazarus JV</searchLink>; Barcelona Institute for Global Health (IS Global), Hospital Clinic, University of Barcelona, Barcelona, Spain; CUNY Graduate School of Public Health and Health Policy, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Matthews+GV%22">Matthews GV</searchLink>; Therapeutic and Vaccine Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia; St Vincent's Hospital, Darlinghurst, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Scheibe+A%22">Scheibe A</searchLink>; TB HIV Care, Cape Town, South Africa; Community Orientated, Primary Care Research Unit, Department of Family Medicine, University of Pretoria, Pretoria, South Africa.<br /><searchLink fieldCode="AU" term="%22Vickerman+P%22">Vickerman P</searchLink>; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Dore+GJ%22">Dore GJ</searchLink>; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Grebely+J%22">Grebely J</searchLink>; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Global+HCV+and+HIV+Treatment+Restrictions+Group%22">Global HCV and HIV Treatment Restrictions Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101690683%22">The lancet. Gastroenterology & hepatology</searchLink> [Lancet Gastroenterol Hepatol] 2024 Apr; Vol. 9 (4), pp. 366-382. <i>Date of Electronic Publication: </i>2024 Feb 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101690683 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2468-1253 (Electronic) <i>NLM ISO Abbreviation: </i>Lancet Gastroenterol Hepatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38367631 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S2468-1253(23)00335-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 366 Titles: – TitleFull: Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Marshall AD – PersonEntity: Name: NameFull: Willing AR – PersonEntity: Name: NameFull: Kairouz A – PersonEntity: Name: NameFull: Cunningham EB – PersonEntity: Name: NameFull: Wheeler A – PersonEntity: Name: NameFull: O'Brien N – PersonEntity: Name: NameFull: Perera V – PersonEntity: Name: NameFull: Ward JW – PersonEntity: Name: NameFull: Hiebert L – PersonEntity: Name: NameFull: Degenhardt L – PersonEntity: Name: NameFull: Hajarizadeh B – PersonEntity: Name: NameFull: Colledge S – PersonEntity: Name: NameFull: Hickman M – PersonEntity: Name: NameFull: Jawad D – PersonEntity: Name: NameFull: Lazarus JV – PersonEntity: Name: NameFull: Matthews GV – PersonEntity: Name: NameFull: Scheibe A – PersonEntity: Name: NameFull: Vickerman P – PersonEntity: Name: NameFull: Dore GJ – PersonEntity: Name: NameFull: Grebely J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2024 Apr Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2468-1253 Numbering: – Type: volume Value: 9 – Type: issue Value: 4 Titles: – TitleFull: The lancet. Gastroenterology & hepatology Type: main |
| ResultId | 1 |